What happened
Genome & Company disclosed a private placement (third-party allotment) to raise US$4.64M, about 2.3% of its market value.
For context, this raise equals about 2.3% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Private placement |
|---|---|
| Raise amount | US$4.64M |
| vs. market value | 2.3% |
| Filed | 2026-04-03, Material event report (rights offering) |
| Source | DART rcept 20260403002950 → open original filing |
Source: DART. Information only, not investment advice.